| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |